Where to now?, page-50

Firstly, apologies to anybody who took any comfort from any of my pre-result analysis without understanding the caveats and limitations.

Here's another loose-footed and probably corrupted piece of analysis, but thought I would throw it out there for anyone who's interested in how ACL's SP is tracking against the two other major bioflops this year (QRX and PBT). My gut says ACL will follow the PBT path, but even so, there's probably a few weeks to pass until the exiters and exited.

ACL is the pink line -->